drugset / Trial / NCT00717093

Study Evaluating The Efficacy Of Varenicline In Cessation Of Oral Smokeless Tobacco Use

NCT00717093

Phase 4 Completed 432 enrolled Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

The primary goal of this study is to compare efficacy of varenicline to placebo for cessation of use of smokeless tobacco.

Timeline

Start
2008-08
Primary completion
2009-04
Completion
2009-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Varenicline Small molecule 1 mg

Indications